Motif Bio Plc Sponsored ADR

( )
MTFB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
CELGCelgene Corporation
AMGNAmgen Inc.
BIIBBiogen Inc.
ONCESpark Therapeutics, Inc.
GILDGilead Sciences, Inc.
REGNRegeneron Pharmaceuticals, Inc.
ILMNIllumina, Inc.
VRTXVertex Pharmaceuticals Incorporated
BPTHBio-Path Holdings, Inc.
SRPTSarepta Therapeutics, Inc.
EXASExact Sciences Corporation
ALXNAlexion Pharmaceuticals, Inc.
AAgilent Technologies, Inc.
IONSIonis Pharmaceuticals, Inc.
INCYIncyte Corporation

Company Profile

Motif Bio Plc is a clinical stage biopharmaceutical company which develops novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It pipeline of antibiotics includes iclaprim, and MTF-001, a preclinical program to design a dihydrofolate reductase inhibitor (DHFRi). The company was founded on November 20, 2014 and is headquartered in New York, NY.